Sertraline HCL Tablets

Notice ID:SPE2D220R0067

This is a modification to invoke Option Year 1 for a contract for Sertraline HCL Tablets, with a performance period from June 28, 2022, through June 27, 2023. The description references several amendments to the original solicitation, which included changes to the solicitation date, the extension of a closing date, and the incorporation of updated clauses and specific tax provisions.

Sertraline HCL Tablets

Notice ID:SPE2D220R0067

The Defense Logistics Agency is planning a national requirements contract for Sertraline HCL Tablets in various strengths and bottle counts. It will be a firm-fixed price contract with a one-year base period and four one-year option periods. The contract will establish a national supply source for multiple government agencies to purchase these commercial items. The solicitation is projected for June 2020, though the agency reserves the right to issue it before or after that date. Performance is for a national supply source, with items purchased through DLA and VA prime vendor programs.

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY (DLA) DLA TROOP SUPPORT
  PSC   6505 DRUGS AND BIOLOGICALS
LOCATION: Not Given
Primary Contact
Phyllis Daraio
215-***-7941

Links (0)

Attachments (0)


Data sourced from SAM.gov. View Official Posting »